Aiforia

Helsinki, Finland  All Finland companies → — Founded 2013
Imaging AI Specialist Point-of-Care Diagnostics
Oncology Pathology Radiology
Pathology AI
Public
Website Claim this company

Products

Aiforia
Aiforia
Pathology AI
Aiforia provides deep learning AI solutions for pathology, offering software that enhances diagnostic capabilities in image analysis for medical discoveries. They offer a comprehensive portfolio of high-performance AI solutions for both clinical and preclinical applications, aiming to improve the speed, accuracy, and consistency of analyzing complex medical images. Aiforia's cloud-based platform is used globally by thousands of pathologists, medical scientists, and researchers in over 50 countries. Over 1 million images have been analyzed and thousands of AI models developed using Aiforia's platform.
Paid, subscription-based

See all 1 product →

About Aiforia

Aiforia is a leading healthcare AI company specializing in deep learning artificial intelligence solutions for pathology. Their software aims to enhance diagnostic capabilities in image analysis, facilitating medical discoveries and improving patient care. The company provides cloud-based platforms that enable pathologists and researchers to analyze digital pathology images more efficiently and consistently. Aiforia’s solutions are designed to automate routine tasks, streamline diagnostic workflows, and support more standardized image analysis and quantification, addressing challenges like rising diagnostic workloads and specialist shortages.

For physicians, Aiforia offers AI-powered pathology platforms that integrate into existing laboratory infrastructures. Their clinical solutions include AI models for various cancer types, such as breast, lung, and prostate cancer, providing tools for comprehensive analysis and reporting. The Aiforia® Create tool allows users, even without prior AI experience, to develop and validate deep learning AI models for histological features and patterns in image analysis. These solutions are designed to increase the speed, accuracy, and consistency of analyzing large and complex medical images, ultimately aiming to improve diagnostic accuracy and patient outcomes.

Focus Areas

AI-powered pathology image analysis deep learning digital pathology oncology neuroscience preclinical research clinical diagnostics

Business Intelligence

TechnologyCloud-based, deep learning AI, Vision Transformer architecture, Foundation Engine, image agnostic, integrates with PACS/LIMS

What Physicians Need to Know

Specialization
Aiforia specializes in deep learning AI solutions for digital pathology, aiming to enhance the speed, accuracy, and consistency of analyzing large and complex medical images.
Key Differentiators
Aiforia's key differentiators include its cloud-based platform, which offers image management, visual analysis, and collaboration tools without requiring coding or dedicated hardware. They also offer a versatile AI model portfolio, including CE-IVD certified diagnostic support tools and custom AI model development. A supervised learning approach prioritizes human oversight and expert input, ensuring transparency and reliability.
Technology Stack
Aiforia leverages deep learning AI and cloud-based technology. Their platform is built with a cloud-native architecture designed for the demands of digital pathology, utilizing Microsoft Azure for storage and compute. They have expanded their AI technology platform to include the Vision Transformer architecture and a proprietary Foundation Engine, which uses foundation models pre-trained on vast image datasets combined with pathologist annotations to accelerate AI model development.
Clinical Applications
Aiforia offers clinical suites for various cancer diagnostics, including breast cancer (grading, ER, PR, HER2, Ki67), lung cancer, prostate cancer, colorectal cancer (QuantCRC), gastric cancer (detection of cancer and H. pylori), and lymph node metastasis. Many of these solutions are CE-IVD marked for diagnostic use in EU and EEA countries.
Research Applications
Aiforia's research solutions provide automated study-centric workflows and image analysis applications for various research areas, including toxicopathology and neuroscience. They enable quantification and discoveries by automating repetitive tasks and supporting GLP frameworks.
AI Model Development
Aiforiau00ae Create is a versatile, cloud-based tool for developing, customizing, and validating deep learning AI models for image analysis in digital pathology. It is designed for pathologists and scientists, requiring no data science or programming expertise, and allows for collaborative work in real-time.
Physician Tip

For physicians, Aiforia's tools aim to increase efficiency, consistency, and diagnostic accuracy in pathology by automating repetitive tasks and providing objective, quantitative, and explainable results. The platform's ease of use and cloud-based nature mean pathologists can leverage advanced AI without needing to be data science experts. The supervised deep learning approach ensures human oversight, and the ability to develop custom AI models allows for tailored solutions to specific diagnostic needs. Aiforia's solutions also support comprehensive case-level review and reporting, combining results from multiple AI models and stainings for first-read diagnostic support.

Aiforia emphasizes seamless integration with existing laboratory infrastructure, including LIS, LIMS, PACS, IMS, and scanners, to enable automated and optimal workflows. They offer publicly available API specifications and have a specialized integration team to ensure smooth implementation. Aiforia also partners with other healthcare technology providers like Dedalus and PathPresenter to integrate their AI solutions directly into pathologists' workflows.

Products by Aiforia

1 product in the directory

Aiforia
Aiforia
Pathology AI
Aiforia provides deep learning AI solutions for pathology, offering software that enhances diagnostic capabilities in image analysis for medical discoveries. They offer a comprehensive portfolio of high-performance AI solutions for both clinical and preclinical applications, aiming to improve the speed, accuracy, and consistency of analyzing complex medical images. Aiforia's cloud-based platform is used globally by thousands of pathologists, medical scientists, and researchers in over 50 countries. Over 1 million images have been analyzed and thousands of AI models developed using Aiforia's platform.
Paid, subscription-based

What the Web Says

Aiforia is a Finnish health technology company specializing in deep learning AI and cloud-based software for analyzing pathology images, primarily for clinical diagnostics, preclinical research, and custom AI model development. Their platform is used by over 5,000 users in 50+ countries and has analyzed over 1 million images, indicating a mature product. Reviews highlight its utility in enhancing efficiency, precision, and consistency in pathology workflows.

Overall: Positive

Strengths

  • Broad portfolio of CE-IVD marked clinical AI models for various cancer types.
  • No-code Aiforia Create tool enables custom AI model development without prior AI experience.
  • Transparent visual overlays provide explainable AI results directly on digital slides.
  • Cloud-based platform with stated ISO 27001, SOC 2 Type II, and ISO 13485 compliance.
  • Automates manual tasks and helps monitor and improve process quality in pathology labs.
  • Integrates with existing laboratory infrastructure, including PACS, LIMS, and major scanners.

Limitations

  • Specific named integrations with lab software (PACS, LIMS) are not explicitly listed, though compatibility is stated.
  • No FDA clearance or ONC certification is mentioned for clinical applications, though CE-IVD marking is present for EU/EEA.
  • Pricing is not published on their website, requiring a demo request.
  • Limited information available on employer reviews from major platforms like Glassdoor or Indeed, making it difficult to assess company culture or work-life balance.

Based on reviews from: EHRAtlas, SourceForge, FeaturedCustomers, Aiforiau00ae Clinical Platform, Clinical solutions - Aiforia, Top 10 Aiforia Alternatives & Competitors in 2026 - G2, Research solutions - Aiforia, Digital pathology and AI: your guide to basics and beyond - Aiforia, Airia Products | Read 35 Reviews on G2, Capterra Reviews from Real Users - TrustRadius, I Tested 5 Best AI Tools for Researchu2014Here's My Honest Review : r/AIAssisted - Reddit, Working at AFIA Insurance Brokerage Services: Employee Reviews | Indeed.com, Afforai Reviews 2026. Verified Reviews, Pros & Cons - Capterra, Best AI Software Products for 2026 - G2, Aporia Reviews 2026: Details, Pricing, & Features - G2, Best AI Assistants for Financial Services: User Reviews from September 2026 - G2, Has anyone landed an i*nterview and job offer from using an AI apply system? - Reddit, adviora.ai Software Pricing, Alternatives & More 2026 | Capterra, Working at aiphone: Employee Reviews | Indeed.com

Last updated: 2026-09-30

Videos

News, demos, and interviews about Aiforia.

Loading videos...

Videos load interactively. If none appear, search YouTube for Aiforia →

View all on YouTube

Press & Coverage

Aiforia Technologies Plc
Aiforia and Stratipath partner to expand access to AI-driven precision diagnostics in oncology
Aiforia and Stratipath announced a strategic partnership to broaden access to AI-driven diagnostic and prognostic tools for pathologists and oncologists in breast cancer. This collaboration aims to enhance precision diagnostics in oncology.
2026-08
fundsforNGOs News
Aiforia Secures u20ac20 Million EU Financing to Advance AI-Powered Cancer Detection
Aiforia has secured u20ac20 million in venture debt financing from the European Investment Bank (EIB) to accelerate the development of its AI-powered platform for digital pathology and cancer detection. The funding will support product development and commercial growth, with the aim of improving patient care through advanced image analysis solutions.
2026-08
Dealroom News
Aiforia Technologies raises ~u20ac6.4M in directed share issue
Finnish medtech firm Aiforia Technologies has raised approximately u20ac6.4 million through a directed share issue to institutional and qualified investors. The net proceeds from this share issue will be used to fund Aiforia's growth strategy.
2026-06
Microsoft Partner Center
Aiforia brings AI-assisted lung cancer analysis to NHS pathology workflows
Aiforia is collaborating with University Hospital Southampton NHS Foundation Trust to implement AI-assisted lung cancer analysis on Microsoft Azure, aiming to support faster and more consistent pathology workflows. This initiative is part of a broader effort to integrate AI into clinical diagnostics within the NHS.
2026-06
Aiforia Technologies Plc
Aiforia expands its presence in Spain through a new clinical account
Aiforia has been selected to provide AI-assisted diagnostic solutions to a regional health service provider in Spain, equipping nine hospitals with AI applications for breast and prostate cancer diagnostics. This expansion strengthens Aiforia's commitment to delivering innovative solutions in Europe.
2026-06
Aiforia Technologies Plc
Aiforia announces the next generation of its CE-IVD marked Prostate Cancer Biopsy AI solution
Aiforia has launched the next generation of its CE-IVD marked clinical AI solution for prostate cancer diagnostics, designed to enhance pathologists' workflow with comprehensive analysis and reporting tools for prostate needle biopsies. This solution is built on Aiforia's Foundation Engine technology for robust performance.
2026-03
Aiforia Technologies Plc
Aiforia and Proscia partner to accelerate AI-driven digital pathology
Aiforia and Proscia have partnered to accelerate the global adoption of AI-driven workflows in anatomic pathology laboratories. This collaboration aims to deliver fully integrated AI-driven digital pathology workflows to enhance efficiency and improve patient outcomes.
2026-03
Aiforia Technologies Plc
Aiforia releases a new CE-IVD marked AI solution for gastric cancer diagnostics
Aiforia Technologies Plc announced the launch of a new CE-IVD marked clinical AI solution for gastric cancer diagnostics. The Aiforiau00ae Gastric Cancer AI application is designed to support pathologists in detecting and reporting gastric cancer in digitized tissue samples.
2026-02

Frequently Asked Questions

Aiforia offers AI-powered solutions primarily for pathology image analysis, aiming to increase speed, accuracy, and consistency in diagnostics. Their clinical suites cover areas like breast, prostate, lung, colorectal, and gastric cancers, as well as lymph node metastasis detection. These solutions provide AI-supported image-based diagnostics with intelligent visualization, assisted screening, and reporting tools within a cloud-based platform. Aiforia also provides 'Aiforiau00ae Create', a tool for developing custom deep learning AI models for various image analysis applications, which can be used for both research and clinical practice.
Aiforia prioritizes data privacy and security, holding several globally relevant quality and security certifications. They have designed and implemented security practices to comply with HIPAA (Health Insurance Portability and Accountability Act) regulations, with an independent audit firm evaluating their controls for HIPAA Security Rule compliance. Additionally, Aiforia has obtained IVDR (In Vitro Diagnostic Regulation) certification, demonstrating that their clinical solutions meet stringent safety, performance, and risk management requirements for diagnostic medical devices in the European Union.
Aiforia offers a scalable business model based on Software as a Service (SaaS). The cost of using Aiforia's software is dependent on factors such as the number of images, the complexity of the analysis, and the amount of cloud storage and user numbers. They offer both annual and usage-based fees. For a specific quote, Aiforia recommends booking a demo to discuss individual needs.
Aiforia provides dedicated support representatives from their team of scientists who work closely with customers, offering proactive guidance and assistance with challenges. Users also gain access to the Aiforia Community, a digital space for peer interaction, a knowledge base with documentation, and tips for annotation and image analysis. Their cloud-based platform is designed for ease of use, requiring no coding or dedicated hardware, and their science team supports AI model development and deployment.
Aiforia has a vast network of partners, including collaborations with Siemens Healthineers, PathPresenter, Dedalus Group, Sectra, and Proscia. These partnerships aim to expand the availability of Aiforia's AI solutions, integrate them into existing laboratory infrastructures and information systems (like LIS and IMS), and provide comprehensive digital pathology workflows. This allows clients to seamlessly access and utilize Aiforia's AI solutions, enhancing diagnostic capabilities and streamlining workflows.
Founded in 2013, Aiforia is a publicly traded company headquartered in Helsinki, Finland, with subsidiaries in the United States and France, and representatives across Europe and North America. They have a global presence with thousands of users in over 50 countries, and over 1 million images have been analyzed on their platform. Aiforia emphasizes its commitment to continuously integrating the latest AI advancements into clinical practice through its Foundation Engine technology.

Related Companies

Pe
Perimeter Medical Imaging AI
Toronto, Canada and Dallas, Texas, USA

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS
Rolle, Switzerland and Boston, Massachusetts, United States

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
DeepBio
Seoul, South Korea

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]
AIRA Matrix
Thane, Maharashtra, India

AIRA Matrix is a healthcare AI company that develops cutting-edge artificial intelligence solutions for life sciences applications, with a strong emphasis on deep learning for medical image analysis. Their innovative products and services are designed to enhance diagnostic accuracy, improve workflow efficiency, and reduce turnaround times in pathology laboratories. The company provides diagnostic, prognostic, and […]
aisencia
Bremen, Germany

aisencia GmbH is a healthcare AI company focused on revolutionizing diagnostic workflows in dermatopathology through artificial intelligence. They develop digital, AI-powered software solutions like Vistaneos and Cutaneos 80, designed to streamline pathology processes for faster, more precise, and accessible cancer diagnoses. The company’s technology aims to classify over 50 types of skin lesions, covering approximately […]
AI Agent

AI Agent, specifically referring to the platform accessible via https://vertexaisearch.cloud.google.com, is now known as the Gemini Enterprise Agent Platform. This platform is Google Cloud’s comprehensive and open solution for building, deploying, scaling, governing, and optimizing production-grade AI agents. It provides a unified environment that integrates machine learning models, such as generative AI agents and search […]
Suggest an Edit → | Report an issue
AI Tool Finder
AI-powered search. Results may not be comprehensive.